Following Smart Money: Baker Brothers Investments In 2013 And Beyond, Part 2 - Seeking Alpha

Following Smart Money: Baker Brothers Investments In 2013 And Beyond, Part 2 - Seeking Alpha

Trade Call Alert: InnerWorkings Inc. (INWK) Price Target = $8.25

Trade Call Alert: InnerWorkings Inc. (INWK) Price Target = $8.25

Video: My Solta-Zeltiq Merger Thesis (Public Free Video)

Video: My Solta-Zeltiq Merger Thesis (Public Free Video)

Solta Medical Inc (SLTM): Zeltiq Aesthetics And Solta Medical Are Likely In Play - Seeking Alpha

Solta Medical Inc (SLTM): Zeltiq Aesthetics And Solta Medical Are Likely In Play - Seeking Alpha

New Update: My Certified Letter to Solta Medical $SLTM

New Update: My Certified Letter to Solta Medical $SLTM

Acorn Energy Stock On The Rise | Investing.com

Acorn Energy Stock On The Rise | Investing.com

Sunshine Heart Inc (SSH): Sunshine Heart's Pulse System Could Revolutionize How Heart Failure Is Treated - Seeking Alpha

Sunshine Heart Inc (SSH): Sunshine Heart's Pulse System Could Revolutionize How Heart Failure Is Treated - Seeking Alpha

Enanta Pharmaceuticals Inc (ENTA): Near-Term Catalyst Could Double Enanta's Market Cap - Seeking Alpha

Enanta Pharmaceuticals Inc (ENTA): Near-Term Catalyst Could Double Enanta's Market Cap - Seeking Alpha

Our Best Small-Cap Biotech Picks For The Rest Of This Year - Seeking Alpha

Our Best Small-Cap Biotech Picks For The Rest Of This Year - Seeking Alpha

$ACRX UPDATED: New Shorterm PT opinion = $12 EOY target = $14

$ACRX UPDATED: New Shorterm PT opinion = $12 EOY target = $14

Acelrx Pharmaceuticals, Inc. ACRX : $ACRX Chart - Ready To Break Out

Acelrx Pharmaceuticals, Inc. ACRX : $ACRX Chart - Ready To Break Out

Antares Pharma Inc (ATRS): Important Upcoming Catalyst For Antares - FDA Decision Expected October 14 - Seeking Alpha

Antares Pharma Inc (ATRS): Important Upcoming Catalyst For Antares - FDA Decision Expected October 14 - Seeking Alpha

5 Biopharmas With Upcoming Catalysts That Should Rally [Antares Pharma Inc] - Seeking Alpha

5 Biopharmas With Upcoming Catalysts That Should Rally [Antares Pharma Inc] - Seeking Alpha

Halozyme 60 Minute, 10 Day Chart Analysis As Of Close, 9/16/13 - Sentime...

Solta Medical Inc (SLTM): Strong Acquisition Target Solta Poised To Challenge In Fat Loss And Skin Care Markets - Seeking Alpha

Solta Medical Inc (SLTM): Strong Acquisition Target Solta Poised To Challenge In Fat Loss And Skin Care Markets - Seeking Alpha

Solta Medical Inc (SLTM): Voce Capital Pushes For Acquisition Of Solta Medical, Activist Investor David Callan Joins In - Seeking Alpha

Solta Medical Inc (SLTM): Voce Capital Pushes For Acquisition Of Solta Medical, Activist Investor David Callan Joins In - Seeking Alpha

Tetraphase Pharmaceuticals Inc (TTPH): Trius Acquired Last Week, Tetraphase Could Be Next - Seeking Alpha

Tetraphase Pharmaceuticals Inc (TTPH): Trius Acquired Last Week, Tetraphase Could Be Next - Seeking Alpha

3 Near-Term Catalysts Could Double Onoconova's Valuation [Array Biopharma Inc] - Seeking Alpha

3 Near-Term Catalysts Could Double Onoconova's Valuation [Array Biopharma Inc] - Seeking Alpha

Biodel Inc (BIOD): BioPharma Catalyst Trade Pick Of The Week: Biodel | Mentions: Astex Pharmaceuticals, Inc. (ASTX), Eli Lilly & Co. (LLY), MannKind Corporation (MNKD) - Seeking Alpha

Biodel Inc (BIOD): BioPharma Catalyst Trade Pick Of The Week: Biodel | Mentions: Astex Pharmaceuticals, Inc. (ASTX), Eli Lilly & Co. (LLY), MannKind Corporation (MNKD) - Seeking Alpha

Video Chart Analysis and Commentary on Trius Therapeutics ($TSRX)

Video Chart Analysis and Commentary on Trius Therapeutics ($TSRX)

Updated:Trade Call Opinion: $TSRX For a Bounce Back Over $8

Updated:Trade Call Opinion: $TSRX For a Bounce Back Over $8

BioDelivery Sciences Primed To Grab Its Share Of The $1.5 Billion Opioid Market - Seeking Alpha

BioDelivery Sciences Primed To Grab Its Share Of The $1.5 Billion Opioid Market - Seeking Alpha

I bought BioDelivery Sciences (BDSI) on Bullish Chart: Solid Small Cap Spec Investment.

I bought BioDelivery Sciences (BDSI) on Bullish Chart: Solid Small Cap Spec Investment.

GTx Pharma Showing Bullish Chart Before Upcoming June Catalyst Data Release

GTx Pharma Showing Bullish Chart Before Upcoming June Catalyst Data Release

I bought Antares @ $3.95, I see a move to $4.35 short term

I bought Antares @ $3.95, I see a move to $4.35 short term

Significant Near-Term Top-Line Data Catalyst And Platform Technology Should Rally Insmed -- Trefis

Significant Near-Term Top-Line Data Catalyst And Platform Technology Should Rally Insmed -- Trefis

Insmed: Top-Line Data Should Rally Stock | Investing.com

Insmed: Top-Line Data Should Rally Stock | Investing.com

Significant Near-Term Top-Line Data Catalyst And Platform Technology Should Propel Insmed - Seeking Alpha

Significant Near-Term Top-Line Data Catalyst And Platform Technology Should Propel Insmed - Seeking Alpha

Near-Term Catalysts And High Insider Ownership Make GTx An Attractive Buy - Seeking Alpha

Near-Term Catalysts And High Insider Ownership Make GTx An Attractive Buy - Seeking Alpha

GTx pursues three drug studies; shares rise - Proactiveinvestors (NA)

GTx pursues three drug studies; shares rise - Proactiveinvestors (NA)

Agenus: Near-Term Drivers With A Market Opportunity Over $17 Billion - Seeking Alpha

Agenus: Near-Term Drivers With A Market Opportunity Over $17 Billion - Seeking Alpha

Biotechs In The Age Of Terror | Investing.com

Biotechs In The Age Of Terror | Investing.com

Cleveland BioLabs Offers Medical Countermeasures Against Potential Terrorist Attacks - Seeking Alpha

Cleveland BioLabs Offers Medical Countermeasures Against Potential Terrorist Attacks - Seeking Alpha

Weekend update with some charts, Market forecast and opinion. (VIDEO)

Weekend update with some charts, Market forecast and opinion. (VIDEO)

AVEO Poised To Move Higher Before FDA Adcomm Catalyst, Obamacare And Platform Potential - Seeking Alpha

AVEO Poised To Move Higher Before FDA Adcomm Catalyst, Obamacare And Platform Potential - Seeking Alpha

Market Commentary for This Week: Changing Course to Bullish - YouTube

Market Commentary for This Week: Changing Course to Bullish - YouTube

Market Forecast for the rest of this week ending 4/12/13 - YouTube

Market Forecast for the rest of this week ending 4/12/13 - YouTube

3 Small Cap Biopharmas Primed To Move Much Higher Now - Seeking Alpha

3 Small Cap Biopharmas Primed To Move Much Higher Now - Seeking Alpha

$AVEO Due Diligence: Catalyst: Adcomm May 2nd | StockMatusow.com

$AVEO Due Diligence: Catalyst: Adcomm May 2nd | StockMatusow.com

Opexa: A Significant Growth Opportunity For Short-Term Traders And Long-Term Investors - Seeking Alpha

Opexa: A Significant Growth Opportunity For Short-Term Traders And Long-Term Investors - Seeking Alpha

Obagi Medical Products Acquired, These Biotechs May Be Next | Investing.com

Obagi Medical Products Acquired, These Biotechs May Be Next | Investing.com

AcelRx Pharmaceutical's Potential Billion-Dollar Treatment Under The Radar - Seeking Alpha

AcelRx Pharmaceutical's Potential Billion-Dollar Treatment Under The Radar - Seeking Alpha

AcelRx Pharmaceuticals Given New $7.00 Price Target at Guggenheim (ACRX) – Mideast Time

AcelRx Pharmaceuticals Given New $7.00 Price Target at Guggenheim (ACRX) – Mideast Time

Significant catalysts and an unfortunate PR mistake present an opportunity in AcelRx Pharmaceuticals. | StockMatusow.com

Significant catalysts and an unfortunate PR mistake present an opportunity in AcelRx Pharmaceuticals. | StockMatusow.com

Significant catalysts and an unfortunate PR mistake present an opportunity in AcelRx Pharmaceuticals. | StockMatusow.com

Significant catalysts and an unfortunate PR mistake present an opportunity in AcelRx Pharmaceuticals. | StockMatusow.com

Significant Catalysts And Company PR Error Present Significant Opportunity In AcelRx Pharmaceuticals

Significant Catalysts And Company PR Error Present Significant Opportunity In AcelRx Pharmaceuticals

AcelRx Pharma Selloff Caused By Error In Recent Press Release | StockMatusow.com

AcelRx Pharma Selloff Caused By Error In Recent Press Release | StockMatusow.com

Trius Therapeutics: New MSRA Treatment Could Bring Billions In Revenues - Seeking Alpha

Trius Therapeutics: New MSRA Treatment Could Bring Billions In Revenues - Seeking Alpha

Download $TSRX Analyst Report | StockMatusow.com

Download $TSRX Analyst Report | StockMatusow.com

Why the latest rally could be a bull trap | StockMatusow.com

Why the latest rally could be a bull trap | StockMatusow.com

Pluristem Receives FDA Orphan Drug Status Designation for Treatment of Aplastic Anemia - Yahoo! Finance

Pluristem Receives FDA Orphan Drug Status Designation for Treatment of Aplastic Anemia - Yahoo! Finance

Upcoming Catalysts For These BioPharmas Provide Potential Upside - Seeking Alpha

Upcoming Catalysts For These BioPharmas Provide Potential Upside - Seeking Alpha

Dara Biosciences, Inc. DARA : $DARA Chart on Verge of Breakout

Dara Biosciences, Inc. DARA : $DARA Chart on Verge of Breakout

AddThis Social Bookmarking Sharing Button Widget

AddThis Social Bookmarking Sharing Button Widget

Pozen: An Undervalued Investment and Catalyst Trade Opportunity

Pozen: An Undervalued Investment and Catalyst Trade Opportunity

Pozen: An Undervalued Investment and Catalyst Trade Opportunity

Pozen: An Undervalued Investment and Catalyst Trade Opportunity

4 Small Cap Biopharmas With Near-Term Catalysts - Seeking Alpha

4 Small Cap Biopharmas With Near-Term Catalysts - Seeking Alpha

3 Stocks Under $5 Making Big Moves - Stockpickr! Your Source for Stock Ideas

3 Stocks Under $5 Making Big Moves - Stockpickr! Your Source for Stock Ideas

Trade Alert: $IMUC price target opinion = $2.55 Catalyst = interim data + bullish chart | StockMatusow.com

Trade Alert: $IMUC price target opinion = $2.55 Catalyst = interim data + bullish chart | StockMatusow.com

The Obesity Epidemic: EnteroMedics' New Treatment Approach - Seeking Alpha

The Obesity Epidemic: EnteroMedics' New Treatment Approach - Seeking Alpha

Mike Matusow Wins 2013 NBC National Heads-Up Poker Championship - Poker News

Mike Matusow Wins 2013 NBC National Heads-Up Poker Championship - Poker News

Athersys: Short Term Catalyst With Long Term Potential

Athersys: Short Term Catalyst With Long Term Potential

Athersys: Upcoming Short Term Catalyst With Promising Longer Term Potential - Seeking Alpha

Athersys: Upcoming Short Term Catalyst With Promising Longer Term Potential - Seeking Alpha

Athersys, Inc. (ATHX) Beginning Due Diligence (chart technicals to come in seperate post) | StockMatusow.com

Athersys, Inc. (ATHX) Beginning Due Diligence (chart technicals to come in seperate post) | StockMatusow.com

BioLineRx: Upcoming Catalyst With Potential Multi Billion-Dollar Schizophrenia Drug - Seeking Alpha

BioLineRx: Upcoming Catalyst With Potential Multi Billion-Dollar Schizophrenia Drug - Seeking Alpha

Closer Look: BioLineRx's Multi Billion Dollar Schizophrenia Drug

Closer Look: BioLineRx's Multi Billion Dollar Schizophrenia Drug

Legendary Investor Icahn Still Slugging Away With Enzon Pharma - Seeking Alpha

Legendary Investor Icahn Still Slugging Away With Enzon Pharma - Seeking Alpha

Legendary Investor Icahn Still Slugging Away With Enzon Pharma - Seeking Alpha

Legendary Investor Icahn Still Slugging Away With Enzon Pharma - Seeking Alpha

Tuesday's Small Cap Biopharma Investment And Catalyst Trade List - Seeking Alpha

Tuesday's Small Cap Biopharma Investment And Catalyst Trade List - Seeking Alpha

Thursday's Small Cap Biotech Catalyst Watch List - Seeking Alpha

Thursday's Small Cap Biotech Catalyst Watch List - Seeking Alpha

Thursday's Small Cap BioTech Catalyst Watch List | Home Page | BioMedReports.Com

Thursday's Small Cap BioTech Catalyst Watch List | Home Page | BioMedReports.Com